Bisphosphonates: Ally or Enemy in the Fight Against Rheumatological Diseases? Two Case Report

• Prif Awduron: Sibel Süzen Özbayrak (Awdur), Berna Günay (Awdur), Emine Unkun Kandemir (Awdur), Nilgün Mesci (Awdur), Duygu Geler Külcü (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Galenos Yayinevi, 2024-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Due to their primary and well-known antiresorptive activity, bisphosphonate (BPs) are commonly prescribed as first-line drugs for osteoporosis treatment. Some reports suggest that they may also possess immunomodulatory and anti-inflammatory properties, along with potential benefits in preventing str...